Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

T 502

Next Previous
Search
Drug Profile

T 502

Alternative Names: Mannan-conjugated allergoids of birch pollen allergens - Inmunotek; T 502

Latest Information Update: 09 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inmunotek
  • Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 06 Jun 2023 Inmunotek completes a phase II trial in Allergic rhinitis and Allergic rhinoconjuctivitis in Germany (EudraCT2020-004126-32)
  • 07 Mar 2023 Inmunotek initiates a phase III trial for Allergic rhinitis and Allergic rhinoconjuctivitis in Germany (SC, Injection)(EudraCT2022-004082-20)
  • 24 Feb 2023 Immunogenicity data from all phase III trials presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI- 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top